Actionable news
0
All posts from Actionable news
Actionable news in AMAG: AMAG Pharmaceuticals, Inc.,

Amag Pharmaceuticals Appoints Edward Myles As Chief Financial Officer

The following excerpt is from the company's SEC filing.

WALTHAM, Mass., April 11, 2016 AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced the appointment of Edward (Ted) Myles as

senior vice president, chief financial officer and treasurer

of AMAG. In this position, Mr. Myles will assume responsibility for AMAGs financial and capital markets activities and will oversee the accounting, tax, corporate finance and investor relations teams. Mr. Myles will report to Frank Thomas, president and chief operating officer of AMAG.

We are pleased to have Ted join us as CFO, said Mr. Thomas. Ted is an accomplished executive with a proven track re cord of financial and operational leadership in the biopharmaceutical industry. His experience in corporate finance, coupled with various roles in accounting and investment banking earlier in his career, make Ted an important addition to the executive leadership team. He will play a critical role in our continued efforts to fund the growth of the company and to create additional shareholder value.

This is an exciting time to join AMAG, said Mr. Myles. I look forward to working with the entire AMAG team to successfully execute the companys business strategy and to further the development of strong relationships with key stakeholders in the investment community.

Mr. Myles brings more than 20 years of public and private corporate finance and operational experience in the biotechnology, pharmaceutical and medical device industries. Prior to joining AMAG, he served in various positions at Ocata Therapeutics, Inc., most recently as chief financial officer and chief operating officer. During his tenure at Ocata, he led the turnaround of the company, which ultimately resulted in its acquisition by Astellas Pharma in February 2016. From 2008 to 2013, Mr. Myles served as chief financial officer and vice president of operations at PrimeraDx, Inc. Prior to that, Mr. Myles was senior vice president of finance and...


More